• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN SERI SURGICAL SCAFFOLD (US)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN SERI SURGICAL SCAFFOLD (US) Back to Search Results
Catalog Number SCF10X25AGEN
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Wound Dehiscence (1154); Capsular Contracture (1761); Erythema (1840); Necrosis (1971); Seroma (2069); Fluid Discharge (2686)
Event Date 03/25/2014
Event Type  Injury  
Event Description
Company representative reported revision reconstruction surgery with implantation of seri and a concomitant cohesive silicone gel device was performed on (b)(6) 2014.Patient initially presented on (b)(6) 2014 with right side erythema overlying the implanted seri, treated with oral bactrim antibiotics.Patient developed capsular contracture, baker grade unknown, with treatment consisting of singulair.During a follow up evaluation, physician diagnosed a seroma resulting in drainage of "yellow, serous fluid" and "pressure necrosis." physician also noted a "[2mm] spot on the incision that is opened," located where a previous tumor was removed.The opening was initially "loosely closed," however, the seri device was eventually fully explanted on (b)(6) 2014, and physician "closed over a drain after debriding all of the non-viable skin." physician noted "all of the skin directly overlying the seri was viable and intact, albeit extremely thin and still not very healthy.But, there was a very distinct line of demarcation exactly at the margin of the seri," the explanted device was discarded and is unavailable for return.
 
Manufacturer Narrative
(b)(4).The physician discarded the device when it was explanted and it is no longer available for return.Therefore, allergan will not receive it and no analysis or testing will be done.The events of necrosis, wound dehiscence, drainage, seroma, erythema, and capsular contracture are surgical/physiological complications and analysis of the device generally does not assist allergan in determining a probable cause for these events.These events are being reported because medical intervention was required, although device-relatedness has not been established.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SERI SURGICAL SCAFFOLD (US)
Manufacturer (Section D)
ALLERGAN
medford MA
Manufacturer Contact
karen herrera
71 s. los carneros rd.
goleta, CA 93117
8059615867
MDR Report Key3848642
MDR Text Key4618333
Report Number3008374097-2014-00030
Device Sequence Number1
Product Code OXF
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K123128
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other
Type of Report Initial
Report Date 05/02/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/31/2015
Device Catalogue NumberSCF10X25AGEN
Device Lot NumberP12081301
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 05/02/2014
Initial Date FDA Received05/21/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/01/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
EXPLANT:; STYLE 410 COHESIVE SILICONE GEL DEVICE; IMPLANT:
Patient Outcome(s) Required Intervention;
Patient Age48 YR
-
-